Evidence map›Paper›PMID 38115808›Full record

ReviewEpilepsia2024

Neurophotonic methods in approach to in vivo animal epileptic models: Advantages and limitations.

Vassiliy Tsytsarev, Julia V Sopova, Elena I Leonova, Mikhail Inyushin, Alisa A Markina, Angelina V Chirinskaite, Anna B Volnova

Open access · greenAbstract readReview
In one paragraph

Review in Epilepsia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Vassiliy TsytsarevDepartment of Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0002-1901-4379
Julia V SopovaCenter of Transgenesis and Genome Editing, Saint Petersburg State University, St. Petersburg, Russia.ORCID https://orcid.org/0000-0002-7825-273X
Elena I LeonovaCenter of Transgenesis and Genome Editing, Saint Petersburg State University, St. Petersburg, Russia.
Mikhail InyushinSchool of Medicine, Universidad Central del Caribe, Bayamon, Puerto Rico.
Alisa A MarkinaInstitute of Translational Biomedicine, Saint Petersburg State University, St. Petersburg, Russia.
Angelina V ChirinskaiteCenter of Transgenesis and Genome Editing, Saint Petersburg State University, St. Petersburg, Russia.
Anna B VolnovaInstitute of Translational Biomedicine, Saint Petersburg State University, St. Petersburg, Russia.
St Petersburg University · RUCentral University of the Caribbean · PRUniversity of Maryland, Baltimore · US

Funding

Build-up of beta-amyloid in the brain in Parkinson's disease-SupplementSC3GM143983 · NIGMS · UNIVERSIDAD CENTRAL DEL CARIBE · PI INYUSHIN, MIKHAIL · 2022 to 2025
$606k
NIGMS NIH HHS SC3 GM143983
6 · The paper itself

Abstract

Neurophotonic technology is a rapidly growing group of techniques that are based on the interactions of light with natural or genetically modified cells of the neural system. New optical technologies make it possible to considerably extend the tools of neurophysiological research, from the visualization of functional activity changes to control of brain tissue excitability. This opens new perspectives for studying the mechanisms underlying the development of human neurological diseases. Epilepsy is one of the most common brain disorders; it is characterized by recurrent seizures and affects >1% of the world's population. However, how seizures occur, spread, and terminate in a healthy brain is still unclear. Therefore, it is extremely important to develop appropriate models to accurately explore the causal relationship of epileptic activity. The use of neurophotonic technologies in epilepsy research falls into two broad categories: the visualization of neural epileptic activity, and the direct optical influence on neurons to induce or suppress epileptic activity. An optogenetic variant of the classical kindling model of epileptic seizures, in which activatable cells are genetically defined, is called optokindling. Research is also underway concerning the application of neurophotonic techniques for suppressing epileptic activity, aiming to bring these methods into clinical practice. This review aims to systematize and describe new approaches that use combinations of different neurophotonic methods to work with in vivo models of epilepsy. These approaches overcome many of the shortcomings associated with classical animal models of epilepsy and thus increase the effectiveness of developing new diagnostic methods and antiepileptic therapy.

Indexed as

EpilepsyKindling, NeurologicAnimalsBrainDisease Models, AnimalHumansSeizuresepilepsy modelsepilepticneurophotonicsoptogeneticsoptokindlingseizures

Identifiers

PMID38115808
PMCPMC10948300
OpenAlexW4390008330

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.